Green Fresh Biotechnology Company Limited (HKG:1084)

Market Cap	585.66M +1.5%
Revenue (ttm)	1.01B -8.5%
Net Income	7.33M -89.4%
EPS	0.01 -89.7%
Shares Out	874.12M
PE Ratio	78.91
Forward PE	n/a
Dividend	0.01 (1.79%)
Ex-Dividend Date	Jun 16, 2026

Volume	4,000
Average Volume	18,600
Open	0.6500
Previous Close	0.6700
Day's Range	0.6500 - 0.6700
52-Week Range	0.5700 - 0.7900
Beta	-0.22
RSI	50.63
Earnings Date	Mar 30, 2026

About HKG:1084

Green Fresh Biotechnology Company Limited, an investment holding company, produces and sells seaweed-based and plant-based hydrocolloid products in China, Europe, rest of Asia, South America, North America, Africa, and Oceania. It operates through five segments: Manufacturing and Sales of Agar-Agar; Manufacturing and Sales of Carrageenan; Manufacturing and Sales of Konjac Products; Manufacturing and Sales of Blended Products; and Others. The company offers hydrocolloid products, including carrageenan, agar agar, and konjac gum and flour. It is ...

• Industry: Farm Products
• Sector: Consumer Staples
• Founded: 2001
• Employees: 1,168
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1084

Financial Performance

In 2025, HKG:1084's revenue was 904.69 million, a decrease of -8.55% compared to the previous year's 989.26 million. Earnings were 6.59 million, a decrease of -89.40%.

Financial numbers in CNY